147 related articles for article (PubMed ID: 9840021)
1. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
Moayyedi P; Ragunathan PL; Mapstone N; Axon AT; Tompkins DS
J Gastroenterol; 1998; 33 Suppl 10():62-5. PubMed ID: 9840021
[TBL] [Abstract][Full Text] [Related]
2. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
Moayyedi P; Ragunathan PL; Mapstone N; Axon AT; Tompkins DS
J Gastroenterol; 1998 Apr; 33(2):160-3. PubMed ID: 9605943
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a nitroimidazole containing tripletherapy regime in Singapore.
Ling KL; Luman W; Ho B; Ng HS
Singapore Med J; 2001 Jul; 42(7):317-21. PubMed ID: 11599627
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.
Moayyedi P; Sahay P; Tompkins DS; Axon AT
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):835-40. PubMed ID: 8574714
[TBL] [Abstract][Full Text] [Related]
5. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
7. Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin.
Toracchio S; Capodicasa S; Soraja DB; Cellini L; Marzio L
Dig Liver Dis; 2005 Jan; 37(1):33-8. PubMed ID: 15702857
[TBL] [Abstract][Full Text] [Related]
8. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
9. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
Wongkusoltham P; Vilaichone RK; Kullavanijaya P; Phaosawadi K; Mahachai V
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S474-80. PubMed ID: 11529378
[TBL] [Abstract][Full Text] [Related]
10. Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy.
Kao AW; Cheng HC; Sheu BS; Lin CY; Sheu MJ; Yang HB; Wu JJ
J Gen Intern Med; 2005 Feb; 20(2):139-42. PubMed ID: 15836546
[TBL] [Abstract][Full Text] [Related]
11. 13C-urea breath test to validate eradication of Helicobacter pylori in an Israeli population.
Gal E; Abuksis G; Fraser G; Koren R; Shmueli C; Yahav Y; Niv Y
Isr Med Assoc J; 2003 Feb; 5(2):98-100. PubMed ID: 12674657
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study.
Bazzoli F; Zagari M; Pozzato P; Varoli O; Fossi S; Ricciardiello L; Alampi G; Nicolini G; Sottili S; Simoni P; Roda A; Roda E
Aliment Pharmacol Ther; 1998 May; 12(5):439-45. PubMed ID: 9663723
[TBL] [Abstract][Full Text] [Related]
13. [Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].
García-Romero E; del Val A; Garrigues V; Cuquerella J; Higón MD; Barrachina M; Pons V; Bixquert M; Ponce J
Gastroenterol Hepatol; 1999 Jan; 22(1):1-6. PubMed ID: 10089703
[TBL] [Abstract][Full Text] [Related]
14. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
15. Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
Bhatia V; Ahuja V; Das B; Bal C; Sharma MP
J Gastroenterol Hepatol; 2004 Jun; 19(6):619-25. PubMed ID: 15151614
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
17. One week triple therapy for Helicobacter pylori associated duodenal ulcer disease.
Luman W; Ling KL; Ng HS
Singapore Med J; 1999 Dec; 40(12):738-41. PubMed ID: 10709423
[TBL] [Abstract][Full Text] [Related]
18. Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment.
Gisbert JP; Ducons J; Gomollón F; Domínguez-Muñoz JE; Borda F; Miño G; Jiménez I; Vázquez MA; Santolaria S; Gallego S; Iglesias J; Pastor G; Hervás A; Pajares JM
Rev Esp Enferm Dig; 2003 Feb; 95(2):121-6, 115-20. PubMed ID: 12760719
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
[TBL] [Abstract][Full Text] [Related]
20. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
